Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Atrial natriuretic peptide promotes uterine decidualization and a TRAIL-dependent mechanism in spiral artery remodeling
Wei Zhang, … , Ningzheng Dong, Qingyu Wu
Wei Zhang, … , Ningzheng Dong, Qingyu Wu
Published September 2, 2021
Citation Information: J Clin Invest. 2021;131(20):e151053. https://doi.org/10.1172/JCI151053.
View: Text | PDF
Research Article Vascular biology

Atrial natriuretic peptide promotes uterine decidualization and a TRAIL-dependent mechanism in spiral artery remodeling

  • Text
  • PDF
Abstract

Atrial natriuretic peptide (ANP) is an important hormone in cardiovascular biology. It is activated by the protease corin. In pregnancy, ANP and corin promote uterine spiral artery remodeling, but the underlying mechanism remains unknown. Here we report an ANP function in uterine decidualization and TNF-related apoptosis-inducing ligand–dependent (TRAIL-dependent) death in spiral arterial smooth muscle cells (SMCs) and endothelial cells (ECs). In ANP- or corin-deficient mice, uterine decidualization markers and TRAIL expression were decreased, whereas in cultured human endometrial stromal cells (HESCs), ANP increased decidualization and TRAIL expression. In uterine spiral arteries from pregnant wild-type mice, SMC and EC loss occurred sequentially before trophoblast invasion. In culture, TRAIL from decidualized HESCs induced apoptosis in uterine SMCs, but not in ECs with low TRAIL receptor expression. Subsequently, cyclophilin B was identified from apoptotic SMCs that upregulated endothelial TRAIL receptor and caused apoptosis in ECs. These results indicate that ANP promotes decidualization and TRAIL expression in endometrial stromal cells, contributing to sequential events in remodeling of spiral arteries, including SMC death and cyclophilin B release, which in turn induces TRAIL receptor expression and apoptosis in ECs.

Authors

Wei Zhang, Shuo Li, Jinglei Lou, Hui Li, Meng Liu, Ningzheng Dong, Qingyu Wu

×

Figure 4

Apoptosis and TRAIL receptor upregulation in human uterine ECs.

Options: View larger image (or click on image) Download as PowerPoint
Apoptosis and TRAIL receptor upregulation in human uterine ECs.
(A and B...
(A and B) Viability of HUtMECs treated with HESC- or dHESC-derived CM (A) or recombinant TRAIL (20 ng/mL) (B) over time (n = 5 per group). (C) Western blotting of TRAIL receptor (R) 1 and 2 in HUtSMCs and HUtMECs (n = 3 per group). (D–F) Viability (D), apoptosis (E), and caspase-3 activity (F) in HUtMECs incubated with CM from SMCs without (SMC CM) or with pretreatment of CM from HESCs (HESC+SMC CM) or dHESCs (dHESC+SMC CM). In E and F, incubation time was 48 hours. (G) TRAIL was added to HUtMECs treated with control (Ctr) medium or CM from SMCs pretreated with dHESC-derived CM. EC viability was measured (n = 5 per group). (H and I) TNFRSF10A and TNFRSF10B mRNA (H) and TRAIL receptor (R) 1 and 2 protein (I) levels were analyzed by real-time PCR and Western blotting, respectively, in HUtMECs treated with Ctr medium or CM from SMCs, HESCs, and dHESCs or SMCs pretreated with CM from HESCs or dHESCs. All quantitative data are mean ± SD and were analyzed by 1-way ANOVA (A, B, and D–H). *P < 0.05; **P < 0.01.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts